 Appraisal new scheme prenatal screening Down syndrome OBJECTIVE new method prenatal screening Down syndrome maternal serum concentrations alpha fetoprotein unconjugated oestriol human chorionic gonadotrophin maternal age triple test DESIGN Examination cost effectiveness triple test relative maternal age range population detection rates SETTING Leicestershire Health Authority MAIN OUTCOME MEASURES Costs affected fetus RESULTS triple test cost effective maternal age risk points amniocentesis detection rate efficient detection rate cost case pounds detection rates likely beneficial CONCLUSIONS Prenatal screening Down syndrome triple test maternal age Individual women preferences use structured decision analysis order utility benefits screening programme